Neural network models help predict immunotherapy efficacy in small cell lung cancer
As immunotherapy makes breakthrough progress in the treatment of small cell lung cancer (SCLC), predicting treatment outcomes ...
MedPage Today2h
Diet and Prostate Cancer; TTFields OK'd for NSCLC; Cancer Studies Retracted
The FDA approved a wearable tumor-treating fields (TTFields) device (Optune Lua) for concurrent use with a PD-1/PD-L1 ...
Morningstar3d
FDA Approves Novocure’s Optune Lua® for the Treatment of Metastatic Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer (NSCLC) Lung cancer is the most common cause of cancer-related death worldwide1, and non-small cell lung cancer (NSCLC) accounts for approximately 85% of all lung cancers.
pharmaphorum1d
NICE backs first targeted therapy for ALK+ lung cancer
In another positive development for the lung cancer community, NICE has also given its blessing to NHS use of MSD's $25 ...
JD Supra3h
Novacure’s Wearable Lung Cancer Treatment Device, Optune Lua, Receives FDA Approval
The FDA has granted approval for Novocure‘s wearable medical device, Optune Lua, designed to treat advanced non-small cell ...
Targeted Oncology7d
Goals of Therapy and Considerations for Treatment Sequencing in Extensive Stage Small Cell Lung Cancer
Ticiana Leal, MD, discusses how in cases of extensive stage small cell lung cancer (ES-SCLC) that progress within 6 months of ...
MassDevice1d
Novocure wins FDA nod for lung cancer treatment wearable
Novocure announced on Tuesday that the FDA treated its Optune Lua wearable device for treating metastatic non-small cell lung ...
The Meadville Tribune1d
Lung cancer screenings save lives, but most people don’t know about them
A significant weapon in the fight against lung cancer may be going to waste, as a survey revealed most Americans aren’t aware ...
National Institute for Health and Care Excellence2d
First targeted treatment to reduce the risk of ALK positive lung cancer returning after complete tumour removal recommended by NICE
First targeted treatment to reduce the risk of ALK positive lung cancer returning after complete tumour removal recommended ...
GlobalData on MSN1d
NovoCure scoops FDA approval on wearable for metastatic cancer treatment
Optune Lua received FDA approval based on data from the pivotal LUNAR trial which demonstrated significant median OS ...
News Medical on MSN6d
Harnessing neural networks to forecast treatment outcomes in small cell lung cancer
As immunotherapy makes breakthrough progress in the treatment of small cell lung cancer (SCLC), predicting treatment outcomes has become a focal point in clinical practice. Immunotherapy combined with ...
News Medical on MSN12d
Medication increases radiation therapy's efficacy for lung cancer that has progressed to brain
Lung cancer accounts for approximately one in five cancer deaths in the United States, making it the primary cause of cancer ...